LELIMA PHARMA

Ottignies-Louvain-la-Neuve ·KBO/BCE: BE 0691.649.590

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	93.5%	55.1%	better than 94% of 4662 sector peers
Net result	€45k	€38k	better than 56% of 4661 sector peers
Equity	€193k	€64k	better than 81% of 4662 sector peers
Gross operating margin	€59k	€61k	better than 48% of 4655 sector peers
Total assets	€207k	€145k	better than 64% of 4662 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€207k
Fixed assets	21/28	€4k
Tangible fixed assets	22/27	€4k
Current assets	29/58	€203k
Amounts receivable within one year	40/41	€104k
Cash & bank	54/58	€98k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€207k
Equity	10/15	€193k
Contributions / capital	10/11	€19k
Reserves	13	€129k
Accumulated profits (losses)	14	€46k
Amounts payable	17/49	€13k
Amounts payable after one year	17	€673
Amounts payable within one year	42/48	€13k
Trade debts payable within one year	44	€3k
Income statement
Gross operating margin	9900	€59k
Operating result	9901	€56k
Financial income	75	€4k
Financial charges	65	€2k
Result before taxes	9903	€58k
Income taxes	67/77	€12k
Net result for the period	9904	€45k
Result to be appropriated	9905	€45k

Summary